Singapore markets close in 4 hours 20 minutes
Straits Times Index
3,301.46 +8.77 (+0.27%) Nikkei
38,244.07 -29.98 (-0.08%) Hang Seng
18,155.28 +392.25 (+2.21%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,446.65 -2,778.87 (-4.61%) CMC Crypto 200
1,261.83 -77.23 (-5.77%)
ABT Jun 2024 55.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:32AM EDT. Market open.
| Previous close | 0.0200 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 55.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.0200 - 0.1600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.